Details for Patent: 7,157,584
✉ Email this page to a colleague
Which drugs does patent 7,157,584 protect, and when does it expire?
Patent 7,157,584 protects EDARBI and EDARBYCLOR and is included in two NDAs.
This patent has sixty-eight patent family members in thirty-two countries.
Summary for Patent: 7,157,584
Title: | Benzimidazole derivative and use thereof |
Abstract: | The present invention relates to a compound represented by the formula (I) ##STR00001## wherein R.sup.1 is a group represented by the formula ##STR00002## wherein R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7 and R.sup.8 are each independently a hydrogen atom or a C.sub.1-6 alkyl, or a salt thereof. The compound of the present invention is useful as an agent for the prophylaxis or treatment of circulatory diseases such as hypertension and the like and metabolic diseases such as diabetes and the like. |
Inventor(s): | Kuroita; Takanobu (Katano, JP), Sakamoto; Hiroki (Amagasaki, JP), Ojima; Mami (Amagasaki, JP) |
Assignee: | Takeda Pharmaceutical Company Limited (Osaka, JP) |
Application Number: | 11/031,057 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,157,584 |
Patent Claim Types: see list of patent claims | Compound; |
Drugs Protected by US Patent 7,157,584
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Azurity | EDARBI | azilsartan kamedoxomil | TABLET;ORAL | 200796-001 | Feb 25, 2011 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
Azurity | EDARBI | azilsartan kamedoxomil | TABLET;ORAL | 200796-002 | Feb 25, 2011 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
Azurity | EDARBYCLOR | azilsartan kamedoxomil; chlorthalidone | TABLET;ORAL | 202331-001 | Dec 20, 2011 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
Azurity | EDARBYCLOR | azilsartan kamedoxomil; chlorthalidone | TABLET;ORAL | 202331-002 | Dec 20, 2011 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 7,157,584
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
Japan | 2004-048928 | Feb 25, 2004 |
International Family Members for US Patent 7,157,584
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 047972 | ⤷ Try a Trial | |||
Argentina | 094588 | ⤷ Try a Trial | |||
Austria | E370136 | ⤷ Try a Trial | |||
Austria | E440095 | ⤷ Try a Trial | |||
Australia | 2005214271 | ⤷ Try a Trial | |||
Brazil | 122012009489 | ⤷ Try a Trial | |||
Brazil | PI0507984 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |